article thumbnail

FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show

Healthcare Dive

Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.

FDA 261
article thumbnail

FDA clarifies cybersecurity recommendations for device makers in new guidance

Healthcare Dive

The draft guidance, which replaces a 2018 document, sets recommendations for how medical device companies should approach cybersecurity in premarket submissions.

FDA 335
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

Healthcare Dive

The administration is ramping up production of medtech guidance, adding 18 draft documents to the list of priorities for the upcoming financial year.

FDA 313
article thumbnail

The Importance of the FDA Debarment List for Clinical Trials

Compliancy Group

Food and Drug Administration (FDA) holding them accountable. Researchers, vendors, and organizations who dont uphold these standards or use data that lacks integrity could face debarment from future clinical trials by the FDA. What Lands Someone on the FDA Debarment List for Clinical Trials?

FDA 52
article thumbnail

The “Food Wars” and the Courts

Bill of Health

Internal documents referenced in the complaint show that Big Food knew what it was doing. He will need to document exactly which and how much of the more than 100 identified UPF products he consumed and to prove that consuming these products actually caused his medical issues.

article thumbnail

Legal Responses to the Potential Dangers of Menstrual Products

Bill of Health

However, low-level exposure to heavy metals also has well documented health effects, including damage to cardiovascular, nervous, endocrine, reproductive, and metabolic systems. Food and Drug Administration (FDA) regulates tampons and menstrual cups as Class II medical devices. Congress has functionally ignored menstrual products.

FDA 100
article thumbnail

FDA finalizes guidance on including patient perspectives in medtech clinical trials

Healthcare Dive

The documents elaborate on how to engage patients to improve trial design and use patient-reported outcomes.

FDA 212